Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease

for the NASH Clinical Research Network

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Vibration-controlled transient elastography estimates liver stiffness measurement (LSM) and controlled attenuation parameter (CAP), which are noninvasive assessments of hepatic fibrosis and steatosis, respectively. However, prior vibration-controlled transient elastography studies reported high failure rates in patients with nonalcoholic fatty liver disease. We examined the performance characteristics of the FibroScan 502 Touch with two probes, medium (M+) and extra large (XL+), in patients with nonalcoholic fatty liver disease in a multicenter setting. A total of 1,696 exams were attempted in 992 patients (body mass index, 33.6 ± 6.5 kg/m2) with histologically confirmed nonalcoholic fatty liver disease. Simultaneous assessment of LSM and CAP was performed using the FibroScan 502 Touch with an automatic probe selection tool. Testing was conducted twice in patients by either a single operator (87%) or two operators (13%). Failure was defined as the inability to obtain a valid examination. An examination was considered unreliable if LSM interquartile range/median was >30%. Significant disagreement between two readings was defined as >95% limits of agreement between two readings. A total of 1,641 examinations yielded valid results with a failure rate of 3.2% (55/1,696). The proportion of unreliable scans for LSM was 3.9%. The proportion of unreliable scans with operator experience in the top quartile (≥59 procedures) was significantly lower than that in the lower three quarters combined (1.6% versus 4.7%, P = 0.02 by Fisher's exact test). The significant disagreement between first and second readings for LSM and CAP when obtained back to back was 18% and 11%, respectively. Conclusion: Vibration-controlled transient elastography for estimation of LSM and CAP can be successfully deployed in a multicenter setting with low failure (3.2%) and high reliability (>95%) rates and high reproducibility. (Hepatology 2018;67:134-144).

Original languageEnglish (US)
Pages (from-to)134-144
Number of pages11
JournalHepatology
Volume67
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Elasticity Imaging Techniques
Vibration
Liver
Reading
Touch
Gastroenterology
Non-alcoholic Fatty Liver Disease
Body Mass Index
Fibrosis

ASJC Scopus subject areas

  • Hepatology

Cite this

Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. / for the NASH Clinical Research Network.

In: Hepatology, Vol. 67, No. 1, 01.01.2018, p. 134-144.

Research output: Contribution to journalArticle

@article{fb41d9af3d1c4867a2363726bbd202d0,
title = "Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease",
abstract = "Vibration-controlled transient elastography estimates liver stiffness measurement (LSM) and controlled attenuation parameter (CAP), which are noninvasive assessments of hepatic fibrosis and steatosis, respectively. However, prior vibration-controlled transient elastography studies reported high failure rates in patients with nonalcoholic fatty liver disease. We examined the performance characteristics of the FibroScan 502 Touch with two probes, medium (M+) and extra large (XL+), in patients with nonalcoholic fatty liver disease in a multicenter setting. A total of 1,696 exams were attempted in 992 patients (body mass index, 33.6 ± 6.5 kg/m2) with histologically confirmed nonalcoholic fatty liver disease. Simultaneous assessment of LSM and CAP was performed using the FibroScan 502 Touch with an automatic probe selection tool. Testing was conducted twice in patients by either a single operator (87{\%}) or two operators (13{\%}). Failure was defined as the inability to obtain a valid examination. An examination was considered unreliable if LSM interquartile range/median was >30{\%}. Significant disagreement between two readings was defined as >95{\%} limits of agreement between two readings. A total of 1,641 examinations yielded valid results with a failure rate of 3.2{\%} (55/1,696). The proportion of unreliable scans for LSM was 3.9{\%}. The proportion of unreliable scans with operator experience in the top quartile (≥59 procedures) was significantly lower than that in the lower three quarters combined (1.6{\%} versus 4.7{\%}, P = 0.02 by Fisher's exact test). The significant disagreement between first and second readings for LSM and CAP when obtained back to back was 18{\%} and 11{\%}, respectively. Conclusion: Vibration-controlled transient elastography for estimation of LSM and CAP can be successfully deployed in a multicenter setting with low failure (3.2{\%}) and high reliability (>95{\%}) rates and high reproducibility. (Hepatology 2018;67:134-144).",
author = "{for the NASH Clinical Research Network} and Raj Vuppalanchi and Siddiqui, {Mohammad S.} and {Van Natta}, {Mark L.} and Erin Hallinan and Danielle Brandman and Kris Kowdley and Neuschwander-Tetri, {Brent A.} and Rohit Loomba and Srinivas Dasarathy and Manal Abdelmalek and Edward Doo and Tonascia, {James A.} and Kleiner, {David E.} and Sanyal, {Arun J.} and Naga Chalasani",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/hep.29489",
language = "English (US)",
volume = "67",
pages = "134--144",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease

AU - for the NASH Clinical Research Network

AU - Vuppalanchi, Raj

AU - Siddiqui, Mohammad S.

AU - Van Natta, Mark L.

AU - Hallinan, Erin

AU - Brandman, Danielle

AU - Kowdley, Kris

AU - Neuschwander-Tetri, Brent A.

AU - Loomba, Rohit

AU - Dasarathy, Srinivas

AU - Abdelmalek, Manal

AU - Doo, Edward

AU - Tonascia, James A.

AU - Kleiner, David E.

AU - Sanyal, Arun J.

AU - Chalasani, Naga

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Vibration-controlled transient elastography estimates liver stiffness measurement (LSM) and controlled attenuation parameter (CAP), which are noninvasive assessments of hepatic fibrosis and steatosis, respectively. However, prior vibration-controlled transient elastography studies reported high failure rates in patients with nonalcoholic fatty liver disease. We examined the performance characteristics of the FibroScan 502 Touch with two probes, medium (M+) and extra large (XL+), in patients with nonalcoholic fatty liver disease in a multicenter setting. A total of 1,696 exams were attempted in 992 patients (body mass index, 33.6 ± 6.5 kg/m2) with histologically confirmed nonalcoholic fatty liver disease. Simultaneous assessment of LSM and CAP was performed using the FibroScan 502 Touch with an automatic probe selection tool. Testing was conducted twice in patients by either a single operator (87%) or two operators (13%). Failure was defined as the inability to obtain a valid examination. An examination was considered unreliable if LSM interquartile range/median was >30%. Significant disagreement between two readings was defined as >95% limits of agreement between two readings. A total of 1,641 examinations yielded valid results with a failure rate of 3.2% (55/1,696). The proportion of unreliable scans for LSM was 3.9%. The proportion of unreliable scans with operator experience in the top quartile (≥59 procedures) was significantly lower than that in the lower three quarters combined (1.6% versus 4.7%, P = 0.02 by Fisher's exact test). The significant disagreement between first and second readings for LSM and CAP when obtained back to back was 18% and 11%, respectively. Conclusion: Vibration-controlled transient elastography for estimation of LSM and CAP can be successfully deployed in a multicenter setting with low failure (3.2%) and high reliability (>95%) rates and high reproducibility. (Hepatology 2018;67:134-144).

AB - Vibration-controlled transient elastography estimates liver stiffness measurement (LSM) and controlled attenuation parameter (CAP), which are noninvasive assessments of hepatic fibrosis and steatosis, respectively. However, prior vibration-controlled transient elastography studies reported high failure rates in patients with nonalcoholic fatty liver disease. We examined the performance characteristics of the FibroScan 502 Touch with two probes, medium (M+) and extra large (XL+), in patients with nonalcoholic fatty liver disease in a multicenter setting. A total of 1,696 exams were attempted in 992 patients (body mass index, 33.6 ± 6.5 kg/m2) with histologically confirmed nonalcoholic fatty liver disease. Simultaneous assessment of LSM and CAP was performed using the FibroScan 502 Touch with an automatic probe selection tool. Testing was conducted twice in patients by either a single operator (87%) or two operators (13%). Failure was defined as the inability to obtain a valid examination. An examination was considered unreliable if LSM interquartile range/median was >30%. Significant disagreement between two readings was defined as >95% limits of agreement between two readings. A total of 1,641 examinations yielded valid results with a failure rate of 3.2% (55/1,696). The proportion of unreliable scans for LSM was 3.9%. The proportion of unreliable scans with operator experience in the top quartile (≥59 procedures) was significantly lower than that in the lower three quarters combined (1.6% versus 4.7%, P = 0.02 by Fisher's exact test). The significant disagreement between first and second readings for LSM and CAP when obtained back to back was 18% and 11%, respectively. Conclusion: Vibration-controlled transient elastography for estimation of LSM and CAP can be successfully deployed in a multicenter setting with low failure (3.2%) and high reliability (>95%) rates and high reproducibility. (Hepatology 2018;67:134-144).

UR - http://www.scopus.com/inward/record.url?scp=85038237482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038237482&partnerID=8YFLogxK

U2 - 10.1002/hep.29489

DO - 10.1002/hep.29489

M3 - Article

VL - 67

SP - 134

EP - 144

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 1

ER -